Prof. Dr. med. Kai-Uwe Eckardt



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference (2016) Macdougall IC, Bircher AJ, Eckardt KU, Obrador GT, Pollock CA, Stenvinkel P, Swinkels DW, et al. Journal article The impact of hypoxia on nephrogenesis (2016) Buchholz B, Schley G, Eckardt KU Journal article Prevalence and Modifiable Determinants of Non-Adherence in Adult Kidney Transplant Recipients in a German Sample (2016) Reber ST, Morawa E, Stößel L, Jank S, Vitinius F, Eckardt KU, Erim Y Journal article Development and validation of cardiovascular risk scores for haemodialysis patients (2016) Anker SD, Gillespie IA, Eckardt KU, Kronenberg F, Richards S, Drueke TB, Stenvinkel P, et al. Journal article Chronic Kidney Disease (Not) on the Agenda (2016) Eckardt KU Journal article, Editorial Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice (2016) Gansevoort RT, Arici M, Benzing T, Birn H, Capasso G, Covic A, Devuyst O, et al. Journal article Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients (2016) Stenvinkel P, Gillespie IA, Tunks J, Addison J, Kronenberg F, Drueke TB, Marcelli D, et al. Journal article HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond (2016) Maxwell PH, Eckardt KU Journal article Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program (ESP): A Single-Center Experience from 2008 to 2013 (2016) Jacobi J, Beckmann S, Heller K, Hilgers KF, Apel H, Spriewald B, Eckardt KU, Amann KU Journal article C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) (2016) Mc Causland FR, Claggett B, Burdmann EA, Eckardt KU, Kewalramani R, Levey AS, Mcmurray JJV, et al. Journal article